南新制药跌10.82% 2020年上市募12亿元西部证券保荐

Group 1 - Nanjing Pharmaceutical's stock closed at 13.27 yuan, experiencing a decline of 10.82%, currently in a state of breaking issue [1] - The company was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on March 26, 2020, with an initial offering price of 34.94 yuan per share, issuing 35 million shares [1] - The total amount raised from the initial public offering (IPO) was 1.223 billion yuan, with a net amount of 1.135 billion yuan, exceeding the originally planned fundraising by 466 million yuan [1] Group 2 - In 2021, Nanjing Pharmaceutical announced a capital reserve distribution plan, increasing its total share capital from 140 million shares to 196 million shares by distributing 0.4 shares for each share held [2] - In 2022, the company further increased its total share capital to 274.4 million shares by distributing an additional 0.4 shares for each share held [2]